Current status of DNA vaccines and their route of administration

被引:24
作者
Alpar, HO [1 ]
Bramwell, VW [1 ]
机构
[1] Univ London, Sch Pharm, Ctr Drug Delivery Res, London WC1N 1AX, England
来源
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2002年 / 19卷 / 4-5期
关键词
DNA; vaccine; cancer; allergy; infectious diseases;
D O I
10.1615/CritRevTherDrugCarrierSyst.v19.i45.20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review is aimed at bringing DNA vaccines into perspective with regard to other currently available vaccines and vaccine strategies in development. It is concluded that, encouragingly, DNA vaccines still offer significant potential, with more recent developments such as improved vectors and delivery systems likely to have an important impact; and in addition, the potential safety of DNA as a vaccine is becoming increasingly apparent. Strategies for oral delivery may be suitable for some applications, with all nonparenteral routes likely to require suitable carriers or adjuvants. The diversity of experimental data attests to the increasing interest in vaccination for the treatment and prevention of disease.
引用
收藏
页码:307 / 383
页数:77
相关论文
共 508 条
[31]   Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees [J].
Bagarazzi, ML ;
Boyer, JD ;
Ugen, KE ;
Javadian, MA ;
Chattergoon, M ;
Shah, A ;
Bennett, M ;
Ciccarelli, R ;
Carrano, R ;
Coney, L ;
Weiner, DB .
VACCINE, 1998, 16 (19) :1836-1841
[32]   Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees [J].
Bagarazzi, ML ;
Boyer, JD ;
Javadian, MA ;
Chattergoon, M ;
Dang, K ;
Kim, G ;
Shah, J ;
Wang, B ;
Weiner, DB .
JOURNAL OF MEDICAL PRIMATOLOGY, 1997, 26 (1-2) :27-33
[33]  
Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196
[34]   Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: An alternative to cationic liposome/DNA aggregates [J].
Bally, MB ;
Zhang, YP ;
Wong, FMP ;
Kong, S ;
Wasan, E ;
Reimer, DL .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 24 (2-3) :275-290
[35]   Neurobiology - An immunization against Alzheimer's? [J].
Barinaga, M .
SCIENCE, 1999, 285 (5425) :175-+
[36]   Making the most of mucin: A novel target for tumor immunotherapy [J].
BarrattBoyes, SM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (03) :142-151
[37]   PROTECTION AGAINST MYCOPLASMA-INFECTION USING EXPRESSION-LIBRARY IMMUNIZATION [J].
BARRY, MA ;
LAI, WC ;
JOHNSTON, SA .
NATURE, 1995, 377 (6550) :632-635
[38]   EFFICIENT GENE-TRANSFER INTO MAMMALIAN PRIMARY ENDOCRINE-CELLS WITH LIPOPOLYAMINE-COATED DNA [J].
BEHR, JP ;
DEMENEIX, B ;
LOEFFLER, JP ;
MUTUL, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :6982-6986
[39]   Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma [J].
Bellone, M ;
Cantarella, D ;
Castiglioni, P ;
Crosti, MC ;
Ronchetti, A ;
Moro, M ;
Garancini, MP ;
Casorati, G ;
Dellabona, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2651-2656
[40]   Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia [J].
Ben-Efraim, S ;
Bizzini, B ;
Relyveld, EH .
BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (05) :268-273